FEDERALpresidential document

National Hepatitis Testing Day, 2024

May 17, 2024

public health hepatitis healthcare access vaccination medical research

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

The Frame

What this does

This proclamation highlights federal health priorities and proposed policy changes regarding the diagnosis and treatment of viral hepatitis in the United States.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

Uninsured individuals

The proposed subscription model for hepatitis C drugs aims to expand access to medication for this group.

Medicaid enrollees

The proposed subscription model for hepatitis C drugs includes individuals enrolled in Medicaid.

Healthcare professionals

The administration's plan includes investments in training programs for healthcare professionals.

What changed

Last recorded activity May 17, 2024.

What's next

Next step not available in the current record.

Summary

President Biden issued a proclamation designating May 19, 2024, as National Hepatitis Testing Day to raise awareness about viral hepatitis. The document highlights the administration's proposed plans to increase testing, expand access to treatments, and improve vaccination rates for hepatitis B and C.

Key Facts

May 19, 2024, is designated as National Hepatitis Testing Day.
Hepatitis C is curable with treatment that is 95 percent effective.
The administration proposes a subscription model to expand access to hepatitis C drugs for uninsured and specific public program enrollees.
The CDC recommends hepatitis B vaccination for children and screening/vaccination for adults under 60.

Frequently Asked Questions

What is the purpose of National Hepatitis Testing Day?

It is intended to raise awareness about viral hepatitis and encourage Americans to get tested and vaccinated.

What specific actions is the administration proposing regarding hepatitis?

The administration has proposed a plan to accelerate , launch a for hepatitis C drugs, and increase funding for medical training and research.

Why It Matters

This proclamation highlights federal health priorities and proposed policy changes regarding the diagnosis and treatment of viral hepatitis in the United States.